How much has Pomelo Care raised?
Pomelo Care has $171M disclosed from major rounds in disclosed or reported funding. The latest public valuation/status is $1.7B Series C valuation.
- Total raised
- $171M disclosed from major rounds
- Disclosed rounds
- 3 major disclosed entries
- Latest round
- Series C ($92M)
- Latest valuation
- $1.7B Series C valuation
- First raised
- Jun 2023 Seed/Series A
- Notable backer
- Notable growth investors and existing backers
Pomelo Care's funding rounds
Pomelo Care's public funding trajectory runs from Jun 2023 to Jan 2026.
- Jun 2023Seed/Series A — valuation not disclosed$33M led/backed by Andreessen Horowitz and First Round Capital.
- Jun 2024Series B — valuation not disclosed$46M led/backed by First Round Capital and a16z Bio + Health.
- Jan 2026Series C — $1.7B valuation$92M led/backed by Notable growth investors and existing backers.
How much has Pomelo Care raised in total?
Pomelo Care has $171M disclosed from major rounds in disclosed or reported funding. The profile lists only public amounts and clearly marks undisclosed valuations or rounds.
The major funding entries are Jun 2023 Seed/Series A: $33M, valuation not disclosed, led/backed by Andreessen Horowitz and First Round Capital; Jun 2024 Series B: $46M, valuation not disclosed, led/backed by First Round Capital and a16z Bio + Health; Jan 2026 Series C: $92M, $1.7B valuation, led/backed by Notable growth investors and existing backers.
Who are Pomelo Care's investors?
Notable investors or backers include Andreessen Horowitz and First Round Capital, First Round Capital and a16z Bio + Health, Notable growth investors and existing backers. These investors are relevant because they shape board expectations around growth, governance, hiring, and follow-on capital discipline.
Why did the valuation move or stay undisclosed?
The latest public valuation is $1.7B Series C valuation. The valuation is tied to market demand, product differentiation, growth expectations, and proof that the company can scale healthcare outcomes or workflow ROI.
Is Pomelo Care profitable, and will it IPO?
Pomelo Care has not publicly disclosed audited profitability or IPO timing. Treat IPO readiness as speculative until management files, announces a transaction, or publishes financials.
What does Pomelo Care's funding mean if you sell into them?
The funding signal suggests budget capacity, but not automatic spend. Sellers should map to the active initiative funded by the round: market expansion, clinical operations, AI/data tooling, compliance, workforce, integrations, or payer/provider partnerships.
As of June 2026.Sources:Pomelo aboutPomelo $33MPomelo $46M Series BPomelo Series C
Pomelo Care — frequently asked questions
